Basecamp Research Secures $60M to Revolutionize AI Drug Discovery with Broad Institute Partnership

AI drug discovery, Basecamp Research, Broad Institute, David R. Liu, Biotechnology, Gene therapy, Artificial intelligence in biology

Eli Lilly and Insitro Collaborate on AI-Driven Therapies for Metabolic Diseases

Eli Lilly, Insitro, AI, Metabolic Diseases, Drug Development, Strategic Agreements, siRNA Therapies, Antibody Therapy, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)